DJ Novavax Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ slid 1.16% to $10.22 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.29% to 26,506.99 and Dow Jones Industrial Average falling 0.51% to 53,414.25.
The stock's fall snapped a five-day winning streak.
Novavax Inc. closed 14.62% below its 52-week high of $11.97, which the company reached on February 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 1.15% to $275.23, Pfizer Inc. $(PFE)$ fell 1.25% to $28.45, and Merck & Co. Inc. (MRK) fell 1.32% to $150.33.
Trading volume (5.1 M) eclipsed its 50-day average volume of 4.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 4, 2026.